Quest Diagnostics, Inc. engages in the provision fo diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.
Highlights
Quest Diagnostics's quick ratio has surged by 62% YoY
Quest Diagnostics's equity has increased by 7% YoY and by 3.1% from the previous quarter
The net income has contracted by 5% from the previous quarter but it has grown by 3% YoY
DGX's EPS is down by 4.9% since the previous quarter but it is up by 3.9% year-on-year
DGX's price to earnings (P/E) is 26% higher than its 5-year quarterly average of 17.5 and 24% higher than its last 4 quarters average of 17.7
Quest Diagnostics's debt has increased by 13% YoY and by 12% QoQ
Key stats
What are the main financial stats of DGX
Market
Shares outstanding
134.3M
Market cap
$16.5B
Enterprise value
$20.65B
Valuations
Price to earnings (P/E)
21.97
Price to book (P/B)
2.82
Price to sales (P/S)
2.19
EV/EBIT
18.02
EV/EBITDA
13.91
EV/Sales
2.74
Earnings
Revenue
$7.53B
EBIT
$1.15B
EBITDA
$1.48B
Free cash flow
$907M
Per share
EPS
$5.59
Free cash flow per share
$6.77
Book value per share
$43.6
Revenue per share
$56.2
TBVPS
$37.76
Balance sheet
Total assets
$12.99B
Total liabilities
$7.11B
Debt
$5.14B
Equity
$5.83B
Working capital
$537M
Liquidity
Debt to equity
0.88
Current ratio
1.29
Quick ratio
1.15
Net debt/EBITDA
2.8
Margins
EBITDA margin
19.7%
Gross margin
33.4%
Net margin
10%
Operating margin
15.1%
Efficiency
Return on assets
6%
Return on equity
13.2%
Return on invested capital
16.2%
Return on capital employed
10.3%
Return on sales
15.2%
Dividend
Dividend yield
1.8%
DPS
$2.21
Payout ratio
39.5%
DGX stock price
How has the Quest Diagnostics stock price performed over time
Financial performance
How have Quest Diagnostics's revenue and profit performed over time
Revenue
$7.53B
Gross profit
$2.51B
Operating income
$1.13B
Net income
$752M
Gross margin
33.4%
Net margin
10%
The company's operating margin rose by 6% YoY
The net income has contracted by 5% from the previous quarter but it has grown by 3% YoY
DGX's operating income is up by 5% year-on-year but it is down by 2.1% since the previous quarter
Quest Diagnostics's net margin has increased by 4.2% YoY but it has decreased by 3.8% QoQ
Growth
What is Quest Diagnostics's growth rate over time
Valuation
What is Quest Diagnostics stock price valuation
P/E
21.97
P/B
2.82
P/S
2.19
EV/EBIT
18.02
EV/EBITDA
13.91
EV/Sales
2.74
DGX's price to earnings (P/E) is 26% higher than its 5-year quarterly average of 17.5 and 24% higher than its last 4 quarters average of 17.7
DGX's EPS is down by 4.9% since the previous quarter but it is up by 3.9% year-on-year
The stock's price to book (P/B) is 18% more than its last 4 quarters average of 2.4 and 8% more than its 5-year quarterly average of 2.6
Quest Diagnostics's equity has increased by 7% YoY and by 3.1% from the previous quarter
The stock's price to sales (P/S) is 29% more than its 5-year quarterly average of 1.7 and 22% more than its last 4 quarters average of 1.8
Efficiency
How efficient is Quest Diagnostics business performance
Quest Diagnostics's return on invested capital has decreased by 14% YoY and by 7% QoQ
DGX's return on assets is down by 8% since the previous quarter and by 6% year-on-year
DGX's ROE is down by 7% since the previous quarter and by 3.6% year-on-year
DGX's return on sales is up by 4.1% year-on-year
Dividends
What is DGX's dividend history
DPS
$2.21
Dividend yield
1.8%
Payout ratio
39.5%
Recent dividends
Financial health
How did Quest Diagnostics financials performed over time
The total assets is 83% greater than the total liabilities
The current ratio has soared by 57% YoY but it has decreased by 7% QoQ
The company's total liabilities rose by 14% YoY and by 12% QoQ
Quest Diagnostics's debt is 12% lower than its equity
Quest Diagnostics's debt has increased by 13% YoY and by 12% QoQ
The company's debt to equity rose by 9% QoQ and by 6% YoY
All financial data is based on trailing twelve months (TTM) periods - updated
quarterly, unless otherwise specified.